| Extracorporeal Photopheresis for Steroid-Refractory Graft-Versus-Host Disease in Recipients of T-Cell Deplete Allogeneic Peripheral Blood Stem Cells. P Baptista, S Anteh, M Cuadrado, F Child, F Dazzi, M Kenyon, YT Leung, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Haploidentical transplant with post-transplant cyclophosphamide for acute myeloid leukaemia and myelodysplastic syndromes patients: the role of previous lines of therapy D Avenoso, F Serpenti, LB Slonim, S Bouziana, F Dazzi, G Hannah, ... Mediterranean Journal of Hematology and Infectious Diseases 16 (1), 2024 | | 2024 |
| PREVIOUS BUSULFAN EXPOSURE IS NOT A CONTRAINDICATION FOR SECOND ALLOGRAFT WITH REDUCED INTENSITY TREOSULFAN BASED CONDITIONING FOLLOWED BY IN-VIVO T-CELL DEPLETED UNRELATED … A Maraj, D Avenoso, M Kenyon, P Krishnamurthy, V Mehra, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 267-268, 2023 | | 2023 |
| RETROSPECTIVE REVIEW OF DONOR LYMPHOCYTE REQUESTS TO ANTHONY NOLAN REGISTRY SHOW EXCELLENT DONOR AVAILABILITY AND VERY LOW RATES OF DONOR ATTRITION AND MEDICAL CLEARANCE FAILURE A Pryce, R Maniusyte, A O'Leary, C Burlton, P Johnson, J Lee, R Pearce, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 597-598, 2023 | | 2023 |
| FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA. THE KING'S COLLEGE HOSPITAL 10 YEARS'EXPERIENCE IN … D Avenoso, A Alabdulwahab, M Kenyon, V Mehra, P Krishnamurthy, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 454-454, 2023 | | 2023 |
| SYSTEMATIC SCREENING FOR VENOUS OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTIVE SYNDROME (VOD/SOS) IS ASSOCIATED WITH EARLIER DIAGNOSIS AND PROMPT INSTITUTION OF DEFIBROTIDE TREATMENT … D Avenoso, M Kenyon, P Krishnamurthy, V Mehra, S Gandhi, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 526-526, 2023 | | 2023 |
| PREVIOUS BUSULFAN IS NOT A CONTRAINDICATION FOR SECOND ALLOGRAFT WITH REDUCED INTENSITY TREOSULFAN-BASED CONDITIONING REGIMEN FOLLOWED BY ALLOGENEIC HAEMATOPOIETIC STEM-CELL … A Maraj, D Avenoso, M Kenyon, P Krishnamurthy, V Mehra, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 261-262, 2023 | | 2023 |
| Myeloablative dose of busulfan and fludarabine combined with in vivo T cell depletion is safe and effective conditioning for acute myeloid leukemia and myelodysplastic syndrome … D Avenoso, V Mehra, LB Slonim, M de Farias, H Alshehri, S Bouziana, ... Transplantation and Cellular Therapy 29 (11), 698. e1-698. e6, 2023 | 1 | 2023 |
| Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answer S Corbacioglu, SA Grupp, PG Richardson, R Duarte, A Pagliuca, T Ruutu, ... Bone marrow transplantation 58 (8), 839-841, 2023 | 6 | 2023 |
| Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and … M Mohty, F Malard, AS Alaskar, M Aljurf, M Arat, P Bader, F Baron, ... Bone marrow transplantation 58 (7), 749-754, 2023 | 30 | 2023 |
| Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients R Suribhatla, T Starkey, MC Ionescu, A Pagliuca, A Richter, LYW Lee British Journal of Haematology 201 (5), 813-823, 2023 | 23 | 2023 |
| Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre … SA Grupp, S Corbacioglu, HJ Kang, T Teshima, SL Khaw, F Locatelli, ... The Lancet Haematology 10 (5), e333-e345, 2023 | 17 | 2023 |
| Fludarabine-Melphalan-Campath, followed by unmanipulated peripheral-blood haematopoietic stem cells, can still cure lymphoma D Avenoso, A Alabdulwahab, M Kenyon, V Mehra, P Krishnamurthy, ... Mediterranean Journal of Hematology and Infectious Diseases 15 (1), 2023 | | 2023 |
| COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) F Marchesi, J Salmanton-García, Z Emarah, K Piukovics, M Nucci, ... Haematologica 108 (1), 22, 2023 | 26 | 2023 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 69 | 2022 |
| Multi-Centre UK Study of Allogeneic Haematopoietic Stem Cell Graft Cryopreservation Effects on Patient Outcomes R Maniusyte, A Pryce, R Pearce, JA Snowden, R Malladi, V Potter, J Lee, ... Blood 140 (Supplement 1), 7552-7554, 2022 | | 2022 |
| Prevalence of Sars-Cov-2 in Stem Cell Donors from Anthony Nolan UK Stem Cell Registry: Sars-Cov-2 Testing Programme, Impact on Stem Cell Collections and Managing Risk Going Forward A Pryce, R Maniusyte, P Johnson, L Hitchinson, A O'leary, A Pagliuca, ... Blood 140 (Supplement 1), 4697-4698, 2022 | | 2022 |
| Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with … D Avenoso, M Kenyon, V Mehra, P Krishnamurthy, A Kulasekararaj, ... Frontiers in Transplantation 1, 996003, 2022 | 1 | 2022 |
| Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients R Suribhatla, T Starkey, MC Ionescu, A Pagliuca, A Richter, LYW Lee MedRxiv, 2022.11. 07.22281786, 2022 | 6 | 2022 |
| Excellent outcome with fb4 regimen in patients with myeloid malignancies older than 55 and with hct-ci score D Avenoso, M de Farias, H Alshehri, P Krishnamurthy, V Mehra, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 164-164, 2022 | | 2022 |
